Profile data is unavailable for this security.
About the company
PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy. The Company is an online provider of prescription and non-prescription medications, food, supplements, supplies and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile applications. Its product line contains approximately 15,000 SKUs of pet medications, health products, and supplies. The Company offers various pet supplies, including food, beds, crates, stairs and other pet supplies. PetMeds products include Non-Prescription Medications (OTC) and supplies, and Prescription Medications (Rx). OTC and supplies include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. Rx includes heartworm and flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications.
- Revenue in USD (TTM)276.97m
- Net income in USD-7.55m
- Incorporated1996
- Employees302.00
- LocationPetmed Express Inc420 South Congress AvenueDELRAY BEACH 33445United StatesUSA
- Phone+1 (561) 426-4444
- Fax+1 (800) 600-8285
- Websitehttps://www.1800petmeds.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pineapple Express Cannabis Co | 0.00 | 900.97k | 35.60m | -- | 39.61 | 33.58 | 39.50 | -- | 0.0442 | 0.0442 | 0.00 | 0.0521 | 0.00 | -- | -- | -- | 165.84 | -141.47 | 181.89 | -- | -- | -- | -- | -116.53 | -- | -- | 0.00 | -- | -30.45 | -- | 3.56 | -- | -- | -- |
| Petmed Express Inc | 276.97m | -7.55m | 90.94m | 302.00 | -- | 0.9095 | -- | 0.3283 | -0.3708 | -0.3708 | 13.60 | 4.73 | 1.64 | 6.99 | 142.99 | 917,109.30 | -4.46 | 14.04 | -6.43 | 17.12 | 28.11 | 29.54 | -2.73 | 8.21 | 0.8422 | -- | 0.00 | 100.72 | -6.06 | -1.27 | -98.90 | -63.26 | 49.56 | 7.14 |
| Marimed Inc | 152.15m | -16.68m | 91.11m | 643.00 | -- | 1.28 | -- | 0.5988 | -0.0446 | -0.0446 | 0.4096 | 0.2384 | 0.7889 | 3.29 | 28.11 | 236,626.80 | -8.63 | -13.42 | -10.11 | -17.50 | 44.04 | 49.18 | -10.93 | -14.83 | 0.7291 | 1.46 | 0.4508 | -- | 10.89 | 65.82 | -219.03 | -- | 18.39 | -- |
| HLS Therapeutics Inc | 60.78m | -27.84m | 91.28m | 91.00 | -- | 1.02 | 53.89 | 1.50 | -1.18 | -1.18 | 2.58 | 3.81 | 0.2815 | 0.765 | 7.04 | 922,116.80 | -12.89 | -7.09 | -14.84 | -8.09 | 86.92 | 92.49 | -45.81 | -33.62 | 1.17 | -2.06 | 0.4886 | -- | 2.61 | 0.5345 | -16.67 | -- | -24.71 | -- |
| CareRx Corp | 270.30m | -2.76m | 92.74m | 1.44k | -- | 1.54 | 7.79 | 0.3431 | -0.0668 | -0.0668 | 6.17 | 1.36 | 1.48 | 13.21 | 11.36 | -- | -1.51 | -13.05 | -2.06 | -19.36 | 28.60 | 28.91 | -1.02 | -9.70 | 0.7413 | 0.6565 | 0.544 | -- | -2.88 | 25.54 | 84.27 | -- | 14.34 | -- |
| High Tide Inc | 364.48m | -26.27m | 190.42m | -- | -- | 1.87 | -- | 0.5224 | -0.4764 | -0.4764 | 6.57 | 1.75 | 1.99 | 14.41 | 69.05 | -- | -14.80 | -23.58 | -19.80 | -31.00 | 27.15 | 29.68 | -7.45 | -15.74 | 0.6894 | 0.6044 | 0.318 | -- | 36.66 | 123.48 | 45.22 | -- | 7.54 | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 1.63m | 7.70% |
| Renaissance Technologies LLCas of 31 Mar 2024 | 1.58m | 7.48% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 1.17m | 5.53% |
| Hotchkis & Wiley Capital Management LLCas of 31 Mar 2024 | 1.06m | 5.00% |
| Global X Management Co. LLCas of 31 Mar 2024 | 700.92k | 3.31% |
| AQR Capital Management LLCas of 31 Mar 2024 | 683.03k | 3.23% |
| Arrowstreet Capital LPas of 31 Mar 2024 | 563.89k | 2.67% |
| Numeric Investors LLCas of 31 Mar 2024 | 547.00k | 2.59% |
| Charles Schwab Investment Management, Inc.as of 31 Mar 2024 | 522.97k | 2.47% |
| Geode Capital Management LLCas of 31 Mar 2024 | 483.35k | 2.29% |
